Ulinastatin Injection 1,00,000 I.U (ULID)
Ulinastatin Injection 1,00,000 IU (ULID) is a clinically trusted protease inhibitor used in the management of acute pancreatitis, systemic inflammation, and critical care conditions such as sepsis. It works by reducing harmful enzyme activity and controlling inflammatory responses in the body. This injection is widely used in hospital settings for patients requiring intensive care support. Known for its fast-acting properties and safety profile, it helps improve patient outcomes by minimizing tissue damage and promoting recovery. It is administered under medical supervision and is considered an essential therapy in modern emergency and critical care medicine.
Description
Ulinastatin Injection 1,00,000 IU (ULID) delivers powerful therapeutic action in managing acute inflammatory and critical care conditions. Healthcare professionals use this protease inhibitor to control enzyme activity and reduce tissue damage in conditions such as acute pancreatitis, sepsis, and systemic inflammatory response syndrome. The formulation actively blocks harmful proteases and stabilizes cellular function, which helps the body maintain balance during severe illness.
This injection supports faster recovery by minimizing inflammation and preventing further complications. Doctors administer it in controlled clinical settings to ensure precise dosing and optimal patient response. The formulation acts quickly in the bloodstream, where it regulates enzyme release and protects vital organs from damage caused by excessive inflammatory reactions.
Medical teams rely on this therapy to enhance patient outcomes in intensive care units. It plays a crucial role in reducing hospitalization time and improving recovery rates. The injection also complements other supportive treatments, which strengthens overall care protocols in emergency and critical conditions.
The product maintains high safety and quality standards, which ensures consistent performance during treatment. Healthcare providers prefer it for its targeted mechanism and dependable results in complex medical cases. Proper administration under medical supervision ensures maximum effectiveness and safety for patients.
Ulinastatin Injection 1,00,000 IU (ULID) stands as an essential solution in modern critical care management. It empowers healthcare professionals to take proactive control over severe inflammatory conditions and supports better clinical outcomes through rapid and effective intervention.
- Product Name: Ulinastatin Injection 1,00,000 IU (ULID)
- Drug Class: Protease Inhibitor
- Strength: 1,00,000 IU
- Form: Injection
- Usage: Acute pancreatitis, sepsis, inflammatory conditions
- Administration: Intravenous (IV) under medical supervision
- Storage: Store in a cool, dry place away from light
- Prescription Required: Yes
- Target Area: Critical care & emergency treatment
